Abbott Laboratories (ABT) Other Operating Expenses (2009 - 2026)

Abbott Laboratories (ABT) has 18 years of Other Operating Expenses data on file, last reported at $5.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses rose 8.67% year-over-year to $5.3 billion; the trailing twelve-month figure through Mar 2026 stood at $21.4 billion (up 4.32% YoY), and the FY2025 full-year result was $21.0 billion, up 2.03% from the prior year.
• Other Operating Expenses slipped to $5.3 billion in Q1 2026, from $5.3 billion in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $5.5 billion in Q1 2022 to a low of $4.8 billion in Q1 2023.
• A 5-year average of $5.2 billion and a median of $5.1 billion in 2022 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses increased 12.0% in 2022 and dropped 12.31% in 2023, its largest moves.
• Tracing ABT's Other Operating Expenses over 5 years: stood at $5.1 billion in 2022, then slipped by 1.02% to $5.0 billion in 2023, then climbed by 7.35% to $5.4 billion in 2024, then slipped by 1.17% to $5.3 billion in 2025, then retreated by 0.6% to $5.3 billion in 2026.
• Business Quant data shows ABT's Other Operating Expenses at $5.3 billion in Q1 2026, $5.3 billion in Q4 2025, and $5.5 billion in Q3 2025.